Evidence map›Paper›PMID 27018708›Full record

ArticleThe Journal of clinical investigation2016

Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning.

Dianxin Liu, Marica Bordicchia, Chaoying Zhang, Huafeng Fang, Wan Wei, Jian-Liang Li, Adilson Guilherme, Kalyani Guntur, Michael P Czech, Sheila Collins

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 193 citations in OpenAlex.

  1. Review
  2. Advances in Adipose Tissue Biology.Endocrine reviews · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Extensive location bias of the GPCR-dependent translatome via site-selective activation of mTOR.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. mTORC1 in energy expenditure: consequences for obesity.Nature reviews. Endocrinology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Dianxin Liu
Marica Bordicchia
Chaoying Zhang
Huafeng Fang
Wan Wei
Jian-Liang Li
Adilson Guilherme
Kalyani Guntur
Michael P Czech
Sheila Collins
University of Massachusetts Chan Medical School · US

Funding

Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2000 to 2019
$31.4M
Novel Role of ??-Adrenergic Receptors to Activate the mTOR-S6K1 Signaling PathwayR21DK085412 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI COLLINS, SHEILA · 2010 to 2011
$523k
NIDDK NIH HHS P30 DK057521NIDDK NIH HHS R21 DK085412
6 · The paper itself

Abstract

A classic metabolic concept posits that insulin promotes energy storage and adipose expansion, while catecholamines stimulate release of adipose energy stores by hydrolysis of triglycerides through β-adrenergic receptor (βARs) and protein kinase A (PKA) signaling. Here, we have shown that a key hub in the insulin signaling pathway, activation of p70 ribosomal S6 kinase (S6K1) through mTORC1, is also triggered by PKA activation in both mouse and human adipocytes. Mice with mTORC1 impairment, either through adipocyte-specific deletion of Raptor or pharmacologic rapamycin treatment, were refractory to the well-known βAR-dependent increase of uncoupling protein UCP1 expression and expansion of beige/brite adipocytes (so-called browning) in white adipose tissue (WAT). Mechanistically, PKA directly phosphorylated mTOR and RAPTOR on unique serine residues, an effect that was independent of insulin/AKT signaling. Abrogation of the PKA site within RAPTOR disrupted βAR/mTORC1 activation of S6K1 without affecting mTORC1 activation by insulin. Conversely, a phosphomimetic RAPTOR augmented S6K1 activity. Together, these studies reveal a signaling pathway from βARs and PKA through mTORC1 that is required for adipose browning by catecholamines and provides potential therapeutic strategies to enhance energy expenditure and combat metabolic disease.

Indexed as

3T3-L1 CellsAdaptor Proteins, Signal TransducingAdipose Tissue, BrownAdipose Tissue, WhiteAnimalsCyclic AMP-Dependent Protein KinasesHEK293 CellsHumansInsulinMechanistic Target of Rapamycin Complex 1MiceMice, KnockoutMultiprotein ComplexesReceptors, Adrenergic, betaRegulatory-Associated Protein of mTORRibosomal Protein S6 Kinases, 70-kDaAdaptor Proteins, Signal TransducingCyclic AMP-Dependent Protein KinasesInsulinMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesReceptors, Adrenergic, betaRegulatory-Associated Protein of mTORribosomal protein S6 kinase, 70kD, polypeptide 1Ribosomal Protein S6 Kinases, 70-kDaRibosomal Protein S6 Kinases, 90-kDaRps6ka1 protein, mouseRPTOR protein, humanRptor protein, mouseTOR Serine-Threonine KinasesUCP1 protein, humanUcp1 protein, mouseUncoupling Protein 1

Identifiers

PMID27018708
PMCPMC4855937
OpenAlexW2328791756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.